Zentek Announces Organizational Update and Appointment of Chief Financial Officer

News and research before you hear about it on CNBC and others. Claim your one week free trial for StreetInsider Premium here.

GUELPH, ON / ACCESSWIRE / May 16, 2022 / Zentek Ltd. (“ Zentec “or the” Company “) (Nasdaq: ZTEK)(TSX-V: ZEN), an intellectual property development and commercialization company, announces that Wendy Ford has been named its new Chief Financial Officer (“ CFO “) for the organization. Ms. Ford has more than three decades of experience in finance and accounting leadership roles for private and publicly traded companies. Brian Bosse will leave his role as Chief Financial Officer to focus his efforts on the oversight of operations as Operations Manager.” COO “) of Zentek, with immediate effect.

“Zentek continues to develop top quality talent as we grow and execute our business strategy,” said Greg Fenton, CEO of Zentek. “The breadth and depth of experience that Ms. Ford has brought to her over her 30-year career is impressive, and she will fit perfectly at a time when our business is poised for accelerated growth. I would also like to thank Mr. Bosse for his guidance over the past four years, and I look forward to the contributions he will make in his new role as COO.”

“This is a transformational time for Zentek as it continues to grow across all business lines. The recent Nasdaq listing is a significant milestone, and the strategic opportunities for the company are exciting for management and shareholders. I look forward to working with the to optimize Zentek’s operations and adapt its financial plan to maximize shareholder value and prudently manage capital,” added Ms. Ford.

Most recently, Ms. Ford served as Vice President of Finance and Chief Financial Officer of Mancor Industries, a precision manufacturer of metal components and subassemblies. Previously, Ms. Ford served as Chief Financial Officer of AirBoss of America, a TSX-listed company focused on the preparedness, defense and automotive industries. She has held leadership positions, including in the areas of financial reporting, audit, tax and compliance. Ms. Ford is a Chartered Professional Accountant (CPA) and a graduate of the University of Toronto.

As part of her employment agreement, Ms. Ford will receive 200,000 stock options at an exercise price of CDN$2.59 which will expire in 3 years.

Zentek has also hired a new director of global healthcare sales, Moe Deib, who will take office on May 24, 2022. Mr. Deib will identify and pursue opportunities with new and existing customers to sell patent-pending ZenGUARD technology. of the society. Mr. Deib has over 15 years of healthcare sales experience, most recently as Director of Business Development (International Sales) at Covalon Technologies Ltd. At Covalon, Mr. Deib managed and negotiated complex multi-million dollar projects, primarily in the regions of North America, Asia, Southeast Asia, Middle East and some countries in Africa.

About Zentek Ltd.

Zentek is an intellectual property development and commercialization company focused on next-generation healthcare solutions in the areas of prevention, detection and treatment. Zentek is currently focused on commercializing ZenGUARD”, a patent-pending coating that has been shown to have 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds. as products against infectious diseases.The company also has an exclusive agreement to be the exclusive worldwide commercialization partner for a new aptamer-based rapid pathogen detection technology.

For more information:

Matt Blazei
Tel: (212) 655-0924
E-mail: [email protected]

To learn more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this press release and all material documents relating to the Company may be obtained on ZEN’s SEDAR profile at http://www.sedar.com/.

Forward-looking statements

This press release contains forward-looking statements. Because forward-looking statements address future events and conditions, they, by their very nature, involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information contained in this press release are reasonable, undue reliance should not be placed on such information, which speaks only as of the date of this release. release, and no assurance can be given that such events will occur within the timeframe disclosed or not at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

THE SOURCE: Zentek Ltd.

See the source version on accesswire.com:

Aubrey L. Morgan